To secure FDA De Novo approval by 2025, with plans to launch product in the United States shortly thereafter...
First product to deliver arrhythmia monitoring service utilising Artificial Intelligence...
See-Mode's AI solution aims to reduce reporting time and variation in delivery of care for thyroid ultrasound...
Qritive's AI-powered solutions to be fully integrated with Roche navify Digital Pathology platform...
To enable rapid delivery of treatment to patients...
62% planning to invest in generative AI within the next three years, higher than global (56%)...
To provide early-stage AI startups with a unique platform...
To act as alchemist in adoption of Artificial Intelligence in gastroenterology...
Handles large datasets efficiently and significantly boosts medical reconstruction performance...
Combines advanced auditory technology with intuitive design to improve hearing impairments...